SCHEMBL2492736

SCHEMBL2492736

Cc1ccc(C)c(C2(O)C(=O)Nc3ccc(Cl)cc32)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.50
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
ALOX12 P18054 1/20 0.49
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
BRD4 O60885 4/20 0.44
POLB P06746 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
CBX7 O95931 2/20 0.43
CDYL Q9Y232 2/20 0.43
CDYL2 Q8N8U2 1/20 0.43
CDY1; CDY1B Q9Y6F8 1/20 0.43
CASP6 P55212 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2497474 0.84 BRD4 (0.57) IDO1ALDH1A1KDM4ELMNAGAA
SCHEMBL2497604 0.84 KMT2A (0.51) IDO1ALDH1A1KDM4ELMNAGAA
SCHEMBL2496356 0.82 KMT2A (0.51) IDO1ALDH1A1KDM4ELMNAGAA
SCHEMBL7467300 0.79 GAA (0.56) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL29143044 0.78 ALDH1A1 (0.47) IDO1ALDH1A1KDM4ELMNAGAA
SCHEMBL2496084 0.76 IDO1 (0.43) IDO1ALDH1A1KDM4ELMNAGAA
SCHEMBL2495393 0.76 KMT2A (0.57) IDO1KMT2AMEN1BRD4CBX7
SCHEMBL1464994 0.76 BRD4 (0.59) IDO1ALDH1A1KDM4ELMNAGAA
SCHEMBL2495396 0.76 CBX7 (0.48) IDO1ALDH1A1KDM4ELMNAGAA
SCHEMBL6787357 0.75 IDO1 (0.50) IDO1GAAKMT2AMEN1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 IDO1 4/4885ALDH1A1 2628/4885KDM4E 1528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.